Vol 2, No 4 (2013)
Other materials agreed with the Editors
Published online: 2013-09-03

open access

Page views 642
Article views/downloads 3574
Get Citation

Connect on Social Media

Connect on Social Media

A guide to using Novo Nordisk insulin analogues in patients with type 2 diabetes

Piotr Fichna, Edward Franek, Grzegorz Gajos, Janusz Gumprecht, Teresa Koblik, Adam Krętowski, Maciej Małecki, Ewa Wender-Ożegowska, Bogumił Wolnik, Dorota Zozulińska-Ziółkiewicz
Diabetologia Kliniczna 2013;2(4):150-157.


Consensus of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) clearly states that individualization of treatment, at least partially based on considering the clinical profi le of patients, is crucial for the effectiveness of undertaken medical activities. Finding the optimal therapy is not easy, mainly due to the number of potential insulin therapy regimens, insulin formulations, and most of all clinical variety of patients. This publication is a summary of the discussion between authors on the above subject. It is based on the results of both randomized, controlled clinical trials, as well as reference documentation of individual insulin formulations.